ARX trades 40.1% below Wall Street's consensus target of $18.20.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ARX achieves its forward estimates and maintains a stable P/E multiple of 17.5x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, Accelerant Holdings (ARX) has a Wall Street consensus price target of $18.20, based on estimates from 9 covering analysts. With the stock currently trading at $12.89, this represents a potential upside of +40.1%. The company has a market capitalization of $2.81B.
Analyst price targets range from a low of $16.00 to a high of $20.00, representing a 22% spread in expectations. The median target of $19.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ARX trades at a trailing P/E of -1.7x and forward P/E of 17.5x. Analysts expect EPS to grow +112.0% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
KNSLKinsale Capital Group, Inc. | $6.8B | $295.05 | $433.00 | +40.2% | Hold | 14.9x | 13 |
RYANRyan Specialty Holdings, Inc. | $4.3B | $33.26 | $38.38 | +9.8% | Hold | 17.1x | 19 |
ACGLArch Capital Group Ltd. | $32.8B | $92.04 | $102.57 | +12.5% | Buy | 9.8x | 34 |
RNRRenaissanceRe Holdings Ltd. | $13.0B | $300.93 | $310.75 | +3.9% | Hold | 7.3x | 28 |
HCIHCI Group, Inc. | $2.2B | $167.42 | $126.50 | -22.7% | Buy | 9.4x | 14 |
HRTGHeritage Insurance Holdings, Inc. | $722M | $23.79 | $36.00 | +54.7% | Buy | 5.4x | 9 |
NODKNI Holdings, Inc. | $322M | $15.73 | — | — | — | — | — |
PLMRPalomar Holdings, Inc. | $3.0B | $111.58 | $110.25 | -1.3% | Buy | 11.4x | 11 |
SKWDSkyward Specialty Insurance Group, Inc. | $2.3B | $50.82 | $67.33 | +33.2% | Buy | 10.3x | 11 |
MMCMarsh & McLennan Companies, Inc. | $85.3B | $174.06 | $210.40 | +20.9% | Hold | 16.9x | 26 |
Quick answers to the most common questions about buying ARX stock.
The consensus Wall Street price target for ARX is $18.2, representing 40.1% upside from the current price of $12.89. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARX has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $18.2 implies 40.1% upside from current levels.
With a forward P/E of 17.5422x, ARX trades at a relatively low valuation. The consensus target of $18.2 implies 40.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $20 for ARX, while the most conservative target is $16. The consensus of $18.2 represents the median expectation. These targets typically reflect 12-month expectations.
ARX is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARX stock forecast based on 9 Wall Street analysts shows a consensus price target of $18.2, with estimates ranging from $16 (bear case) to $20 (bull case). The median consensus rating is "Buy".
ARX trades at a forward P/E ratio of 17.5x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ARX, with a "Buy" consensus rating and $18.2 price target (40.1% upside). 8 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARX analyst price targets range from $16 to $20, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.2 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.